➡ Please tell us about your preferences so that we can bring you more of what you want from Nephrology Times!
This content isn’t available here
Access this content and more in the LinkedIn app
Nephrology Times delivers the latest news in nephrological treatments and technologies with the goal of better informing care decisions and improving patient outcomes.
External link for Nephrology Times
💬 TELL US... What do you want more of from Nephrology Times? Abstract summaries, longer pieces on research, expert opinions, trending news? #nephrology #kidney
ACT NOW if you'd like to submit comments to the FDA regarding post-market assessment of chemicals in food. Read more about the issue here ➡️
Final results of the IGNAZ study presented at #KidneyWk showed felzartamab led to sustained proteinuria reduction and reduced eGFR decline in IgAN. #nephrology #iganephropathy #kidneydisease
ICYMI: A batch of the #CKD drug #cinacalcet has been recalled by the FDA. #drugrecall #kidneydisease
PFAS, or "forever chemicals," are just about everywhere. For the first time, a study analyzed the links among PFAS, gut issues, and kidney damage. Two of the authors joined Neph Times for a conversation about their findings. #PFAS #kidneydisease #gutmicrobiome
Nephrology Times reposted this
Ayus' meta-analysis finds faster sodium correction linked to better outcomes, while slower correction, often in severely ill patients, is tied to higher mortality. The focus on ODS may overlook the real risks. It's time for prospective trials in hyponatremia treatment, Joel Topf explains. Read more: https://lnkd.in/dVZWhZ_S
🧠 AKI leads to brain changes, but does it affect dementia risk? #dementia #acutekidneyinjury #kidney
We spoke with Dr. Sagar Nigwekar about interim data from the SEAPORT 1 trial presented at #KidneyWk showing that INZ-701 has potential in the treatment of #calciphylaxis. #kidneydisease #nephrology https://buff.ly/4fUlhFN